Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization

https://www.prnewswire.com/il/news-releases/evogene-announces-major-milestone-in-its-collaboration-with-google-cloud-advancing-chempass-ai-toward-autonomous-small-molecule-discovery-and-optimization-302808856.html

Publish Date: 2026-06-24 08:00:00

Source Domain: www.prnewswire.com

Early Stage Success Criteria Integration: Evogene Ltd. announced a significant milestone in collaboration with Google Cloud, integrating agentic computational systems into its ChemPass AI™ platform to define key clinical and biological success criteria early in the small-molecule development process.
Acceleration of Discovery Timelines: The integration aims to accelerate discovery timelines by enabling earlier identification of molecules that satisfy product requirements, thus reducing costly delays and inefficient resource allocation later in the development process.
Enhanced Scalability: The advancement promises improved scalability in developing innovative small-molecule products through earlier success profiling and deeper understanding of critical success criteria.
Increased Probability of Success: By enabling earlier identification and profiling of molecules that meet product requirements, the new AI system significantly enhances the probability of successful development.
Google Cloud Collaboration: The achievement underscores the successful collaboration between Evogene and Google Cloud to implement advanced AI technologies that streamline complex biological and chemical research.
Vision for Autonomous Computational Systems: This milestone advances Evogene’s vision towards increasingly autonomous computational systems that can predict key success requirements from early stages.
Application of Gemini Models: The integration leverages Google’s Gemini models and Gemini Enterprise Agent Platform to create more comprehensive target profiles that enable better prioritization of compounds from the outset of research.
Potential Impact on Drug Development: These new capabilities may enable Evogene to address complex proteins that are currently challenging in the development of new therapies, thus broadening its potential impact in the pharmaceutical industry.